Kamyar Kalantar-Zadeh M.D. to Medicare
This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Medicare.
Connection Strength
0.209
-
The cost-effectiveness of extended-release calcifediol versus paricalcitol for the treatment of secondary hyperparathyroidism in stage 3-4 CKD. J Med Econ. 2020 Mar; 23(3):308-315.
Score: 0.157
-
Development and Validation of a Prediction Model for Incident Hypothyroidism in a National Chronic Kidney Disease Cohort. J Clin Endocrinol Metab. 2023 10 18; 108(11):e1374-e1383.
Score: 0.051